Acadia Healthcare Q4 revenue rises 6.1%; $996.2M impairment drives net loss
Acadia Healthcare reported fourth-quarter 2025 revenue of $821.5 million, up 6.1% year over year, but posted a net loss of $(13.02) per diluted share compared with net income of $0.35 a year earlier, driven by a $996.2 million non-cash goodwill impairment charge. Adjusted earnings per diluted share fell to $0.07 from $0.64, and the company also gave 2026 guidance calling for revenue of $3.37 to $3.45 billion and adjusted EBITDA of $575 to $610 million, with Debbie Osteen announced as chief executive officer.
Key points
- Q4 2025 adjusted EBITDA was $99.8 million, compared with $153.1 million a year earlier, including a $52.7 million adjustment to professional and general liability reserves.
- Full-year 2025 revenue was $3,312.8 million, up 5.0%, while the full-year net loss was $(12.16) per diluted share.
- 2026 guidance: revenue of $3.37 to $3.45 billion, adjusted EBITDA of $575 to $610 million, and adjusted earnings per diluted share of $1.30 to $1.55.
- Debbie Osteen is identified as Chief Executive Officer; the conference call is scheduled for February 25, 2026 at 9:00 a.m. Eastern Time.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:39 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 25, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.